https://www.selleckchem.com/pr....oducts/talabostat.ht
At 3 months, the blood pressure, LDL-C and glucose control in the intervention group were better than in the control group (all P less then 0.05). At the same time, the overall persistence for secondary prevention medications at 3 months after discharge increased from 201/277 (72.56%) to 303/365 (83.01%, P = 0.001). The persistence for patients taking antiplatelet, hypoglycemic and statins were significantly higher in the intervention group (P less then 0.05). Conclusions Stroke health manager intervention improved the control of blo
Aimer
Commentaire
Partagez
